Safety evaluation of long-term (12 weeks) intake of food containing Lactobacillus brevis subsp. coagulans (Labre) .
Not Applicable
- Conditions
- Healthy adult women
- Registration Number
- JPRN-UMIN000052449
- Lead Sponsor
- Medical Corporation Hokubukai Utsukushigaoka Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Subjects who are participating in clinical research or monitoring (food, pharmaceuticals, cosmetics) other than this research, or plan to participate during this research period (2) Subjects who are judged to be inappropriate for this study with other reasons by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of the values of physical test, hematological test, blood biochemistry test and urinalysis, and the number of adverse events.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Lactobacillus brevis coagulans mechanism action gut microbiome immune modulation healthy women
Safety profile long-term Lactobacillus brevis intake adverse events human clinical studies
Biomarkers gut health immune response Lactobacillus brevis coagulans supplementation healthy adults
Lactobacillus brevis subsp. coagulans comparison other probiotic strains women's health benefits
Clinical evidence Lactobacillus brevis coagulans immunomodulation gut barrier function systematic reviews